AB
IPSC icon

Amalgamated Bank’s Century Therapeutics IPSC Stock Holding History

Amalgamated Bank’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-706
Closed – – 3070
2025
Q1 		$0 Hold
706
– – ﹤0.01% 2955
2024
Q4 		$1K Hold
706
– – ﹤0.01% 2950
2024
Q3 		$1K Hold
706
– – ﹤0.01% 2966
2024
Q2 		$2K Hold
706
– – ﹤0.01% 2956
2024
Q1 		$3K Sell
706
-1,177
-63% -$4.98K ﹤0.01% 2825
2023
Q4 		$6K Sell
1,883
-210
-10% -$383 ﹤0.01% 2927
2023
Q3 		$4K Hold
2,093
– – ﹤0.01% 2984
2023
Q2 		$7K Hold
2,093
– – ﹤0.01% 2982
2023
Q1 		$7K Sell
2,093
-467
-18% -$2.05K ﹤0.01% 2862
2022
Q4 		$13K Hold
2,560
– – ﹤0.01% 2837
2022
Q3 		$25K Hold
2,560
– – ﹤0.01% 2747
2022
Q2 		$22K Buy
2,560
+840
+49% +$8.24K ﹤0.01% 2835
2022
Q1 		$22K Buy
+1,720
New +$22.8K ﹤0.01% 2776

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amalgamated Bank's IPSC Position: Q2 2025 in Review

Amalgamated Bank sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 706 shares.

Amalgamated Bank first reported a position in IPSC in Q1 2022 and held it in 13 quarters. The position peaked at $25K in Q3 2022. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Amalgamated Bank reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 706 Century Therapeutics shares in Q2 2025.
  • Amalgamated Bank first reported a position in Century Therapeutics in Q1 2022 and held it in 13 quarters.
  • Amalgamated Bank's Century Therapeutics position peaked at $25K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.